ARCHIVES

NCAB Task Force Urges New Study Section For Clinical Cancer Research, Sees “Crisis”

This article is from The Cancer Letter archive.

Vol. 19 No. 19 | May 7, 1993

Download PDF Visit The Full Archive

Related Articles

UK’s NICE Set to Deny Payments For Zaltrap In Second-Line Metastatic Colorectal Cancer

June 26, 2013

Ovarian Suppression Treatment Plus Tamoxifen Can Lower Recurrence Risk

December 26, 2014

RFPs Available

May 5, 2000

Leyland-Jones Named Director of Emory’s Winship Cancer Institute

November 17, 2006

Learning From Europeans, U.S. Oncologists Consider Role For Oxaliplatin, 5-FU Infusion

May 31, 2002

Socio-Economic Factors, Access To Care, Associated With More Aggressive Cancers

April 27, 2007